The message is in the press release. “We’re using our unique technology to develop not only antibodies and other antagonists for neurodegenerative diseases, including new intrabodies that are ideal for intracellular vectorization, but also a reliable and accurate antibody test for Covid-19.
The focus right now is on Covid ,.. thats where PMN has unexpected opportunity to access some funding ...